A point on the long term effect of the fludarabine and rituximab association in the Waldenstrom Macroglobulinemia

被引:0
|
作者
Balkaran, Sandy
Leleu, Xavier
机构
来源
HEMATOLOGIE | 2009年 / 15卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:178 / 179
页数:2
相关论文
共 50 条
  • [1] Long-term outcomes to fludarabine and rituximab in Waldenstrom macroglobulinemia
    Treon, Steven P.
    Branagan, Andrew R.
    Ioakimidis, Leukothea
    Soumerai, Jacob D.
    Patterson, Christopher J.
    Turnbull, Barry
    Wasi, Parveen
    Emmanouilides, Christos
    Frankel, Stanley R.
    Lister, Andrew
    Morel, Pierre
    Matous, Jeffrey
    Gregory, Stephanie A.
    Kimby, Eva
    [J]. BLOOD, 2009, 113 (16) : 3673 - 3678
  • [2] Long Term Responses to Fludarabine and Rituximab in Waldenstrom's Macroglobulinemia
    Treon, Steven
    Branagan, Andrew
    Ioakimidis, Leukothea
    Soumerai, Jacob
    Patterson, Christopher
    Wasi, Parveen
    Emmanouilides, Christos
    Frankel, Stanley R.
    Lister, Andrew
    Morel, Pierre
    Matous, Jeffrey
    Gregory, Stephanie A.
    Kimby, Eva K.
    [J]. BLOOD, 2008, 112 (11) : 1051 - 1051
  • [3] Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia
    Souchet, Laetitia
    Levy, Vincent
    Ouzegdouh, Maya
    Tamburini, Jerome
    Delmer, Alain
    Dupuis, Jehan
    Le Gouill, Steven
    Pegourie-Bandelier, Brigitte
    Tournilhac, Olivier
    Boubaya, Marouanne
    Vargaftig, Jacques
    Choquet, Sylvain
    Leblond, Veronique
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (08) : 782 - 786
  • [4] Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenstrom's Macroglobulinemia
    Tedeschi, Alessandra
    Ricci, Francesca
    Goldaniga, Maria Cecilia
    Benevolo, Giulia
    Varettoni, Marzia
    Motta, Marina
    Pioltelli, Pietro
    Gini, Guido
    Barate', Claudia
    Luraschi, Annamaria
    Vismara, Eleonora
    Frustaci, Anna Maria
    Nichelatti, Michele
    Vitolo, Umberto
    Baldini, Luca
    Morra, Enrica
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02): : 231 - 234
  • [5] Combination therapy with rituximab and fludarabine in Waldenstrom's Macroglobulinemia.
    Treon, SP
    Branagan, A
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Lister, A
    Morel, P
    Matous, J
    Enschede, SH
    Kimby, E
    [J]. BLOOD, 2004, 104 (11) : 215A - 215A
  • [6] Long-term responses to thalidomide and rituximab in Waldenstrom's macroglobulinemia
    Soumerai, J. D.
    Branagan, A. R.
    Patterson, C. J.
    Hunter, Z. R.
    Treon, S. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Long Term Toxicity and Follow-up of Waldenstrom's Macroglobulinemia Patients after Salvage Treatment with Fludarabine Cyclophosphamide Rituximab or Bendamustine and Rituximab
    Tedeschi, Alessandra
    Picardi, Paola
    Goldaniga, Maria Cecilia
    Casaluci, Gloria Margiotta
    Benevolo, Giulia
    Ferrero, Simone
    Varettoni, Marzia
    Barate, Claudia
    Gini, Guido
    Visco, Carlo
    Motta, Marina
    Petrizzi, Valeria Belsito
    Zaja, Francesco
    Ravelli, Erica
    Gentile, Massimo
    Frustaci, Anna Maria
    Orsucci, Lorella
    Morra, Enrica
    Gaidano, Gianluca
    Cairoli, Roberto
    [J]. BLOOD, 2015, 126 (23)
  • [8] Fludarabine, Cyclophosphamide and Rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia
    Vladimir, Lazarevic L. J.
    Maria, Liljeholm
    Karin, Forsberg
    Stefan, Soederberg
    Anders, Wahlin
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1209 - 1211
  • [9] Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenstrom Macroglobulinemia Patients
    Xu, XiaoWei
    Wang, Chun
    Wang, YaMin
    Zhou, LiLi
    Bai, HaiTao
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (04) : 422 - 423
  • [10] Fludarabine in Waldenstrom's macroglobulinemia
    Leblond, V
    Choquet, S
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (02) : 239 - 242